Serum C-Reactive Protein Predicts Poor Prognosis in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy
Abstract
Share and Cite
Zeng, Y.C.; Wu, R.; Xiao, Y.P.; Chi, F.; Xue, M.; Zhang, Z.Y.; Xing, R.; Zhong, W.Z.; Wang, S.L.; Tian, X.; et al. Serum C-Reactive Protein Predicts Poor Prognosis in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy. Curr. Oncol. 2015, 22, 20-24. https://0-doi-org.brum.beds.ac.uk/10.3747/co.22.2178
Zeng YC, Wu R, Xiao YP, Chi F, Xue M, Zhang ZY, Xing R, Zhong WZ, Wang SL, Tian X, et al. Serum C-Reactive Protein Predicts Poor Prognosis in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy. Current Oncology. 2015; 22(1):20-24. https://0-doi-org.brum.beds.ac.uk/10.3747/co.22.2178
Chicago/Turabian StyleZeng, Y.C., R. Wu, Y.P. Xiao, F. Chi, M. Xue, Z.Y. Zhang, R. Xing, W.Z. Zhong, S.L. Wang, X. Tian, and et al. 2015. "Serum C-Reactive Protein Predicts Poor Prognosis in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy" Current Oncology 22, no. 1: 20-24. https://0-doi-org.brum.beds.ac.uk/10.3747/co.22.2178